297 related articles for article (PubMed ID: 21243847)
21. The future of microarray technology: networking the genome search.
D'Ambrosio C; Gatta L; Bonini S
Allergy; 2005 Oct; 60(10):1219-26. PubMed ID: 16134986
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilities.
Egalité N; Ozdemir V; Godard B
Pharmacogenomics; 2007 Sep; 8(9):1115-26. PubMed ID: 17924827
[TBL] [Abstract][Full Text] [Related]
23. Genetic research and genetic information: a health information professional's perspective on the benefits and risks.
Cullen R; Marshall S
Health Info Libr J; 2006 Dec; 23(4):275-82. PubMed ID: 17177948
[TBL] [Abstract][Full Text] [Related]
24. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
Mackler BF; Barach M
J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
[TBL] [Abstract][Full Text] [Related]
25. On the edge of tomorrow: fitting genomics into public health policy.
Gerard S; Hayes M; Rothstein MA
J Law Med Ethics; 2002; 30(3 Suppl):173-6. PubMed ID: 12508522
[TBL] [Abstract][Full Text] [Related]
26. DNA microarray applications in functional genomics.
Jares P
Ultrastruct Pathol; 2006; 30(3):209-19. PubMed ID: 16825123
[TBL] [Abstract][Full Text] [Related]
27. Preserving human potential as freedom: a framework for regulating epigenetic harms.
Khan F
Health Matrix Clevel; 2010; 20(2):259-323. PubMed ID: 21243846
[TBL] [Abstract][Full Text] [Related]
28. Using reality mining to improve public health and medicine.
Pentland A; Lazer D; Brewer D; Heibeck T
Stud Health Technol Inform; 2009; 149():93-102. PubMed ID: 19745474
[TBL] [Abstract][Full Text] [Related]
29. [The brave new world of prevention? On the prerequisites and scope of public health genetics].
Ilkilic I; Wolf M; Paul NW
Gesundheitswesen; 2007 Feb; 69(2):53-62. PubMed ID: 17405077
[TBL] [Abstract][Full Text] [Related]
30. Genomics and toxic torts: dismantling the risk-injury divide.
Grodsky JA
Stanford Law Rev; 2007 Apr; 59(6):1671-734. PubMed ID: 17593590
[TBL] [Abstract][Full Text] [Related]
31. Ethical, social and legal implications of genetic testing in liver disease.
van Leeuwen DJ; Bernat JL
Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
[TBL] [Abstract][Full Text] [Related]
32. [Initiative of introducing the applications of genetics for public health purposes in Poland].
Lutyńska A; Krzysztof K; Wysocki MJ
Przegl Epidemiol; 2012; 66(1):113-7. PubMed ID: 22708309
[TBL] [Abstract][Full Text] [Related]
33. Genomics and public health in the United States: signposts on the translation highway.
Gwinn M; Khoury MJ
Community Genet; 2006; 9(1):21-6. PubMed ID: 16490955
[TBL] [Abstract][Full Text] [Related]
34. Ethical, Legal, and Social Issues (ELSI) of Responsible Data Sharing Involving Children in Genomics: A Systematic Literature Review of Reasons.
Rahimzadeh V; Knoppers BM; Bartlett G
AJOB Empir Bioeth; 2020; 11(4):233-245. PubMed ID: 32975491
[TBL] [Abstract][Full Text] [Related]
35. Genomics for public health improvement: relevant international ethical and policy issues around genome-wide association studies and biobanks.
Pang T
Public Health Genomics; 2013; 16(1-2):69-72. PubMed ID: 23548720
[TBL] [Abstract][Full Text] [Related]
36. Genomics and Infectious Diseases: Expert Perspectives on Public Health Considerations regarding Actionability and Privacy.
Walker A; Boyce A; Duggal P; Thio CL; Geller G
Ethics Hum Res; 2020 May; 42(3):30-40. PubMed ID: 32421947
[TBL] [Abstract][Full Text] [Related]
37. Primer on medical genomics. Part XIII: Ethical and regulatory issues.
Hook CC; DiMagno EP; Tefferi A
Mayo Clin Proc; 2004 May; 79(5):645-50. PubMed ID: 15132406
[TBL] [Abstract][Full Text] [Related]
38. The routinisation of genomics and genetics: implications for ethical practices.
Foster MW; Royal CD; Sharp RR
J Med Ethics; 2006 Nov; 32(11):635-8. PubMed ID: 17074820
[TBL] [Abstract][Full Text] [Related]
39. Science and the sources of hype.
Caulfield T; Condit C
Public Health Genomics; 2012; 15(3-4):209-17. PubMed ID: 22488464
[TBL] [Abstract][Full Text] [Related]
40. [Equity, public health and genomics: the legal, social and biotechnology challenge in México].
Oliva-Sánchez PF; Jafif-Cojab M; Akkad-Schaffer I; Waliszewski-Zamorano E
Gac Med Mex; 2013; 149(5):562-8. PubMed ID: 24108344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
